EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
MAR 2022
TABLES
153
PAGES
839
EDITION
7
PRICE
USD 5600
CODE
MCP22151
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What's New for 2022?
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
SELECT PLAYERS
Abbott Laboratories Inc.; Agilent Technologies, Inc.; Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; Bruker Corporation; Carl Zeiss AG; Eppendorf SE; F. Hoffmann-La Roche AG; Hitachi High-Tech Corporation; Illumina, Inc.; Merck KGaA; Oxford Instruments plc; PerkinElmer Inc.; QIAGEN N.V.; Shimadzu Corporation; Thermo Fisher Scientific Inc.
SEGMENTS
» Technology (Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies, Other Technologies) » End-Use (Healthcare, Biopharmaceutical Companies, Government & Academic, Other End-Uses)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Middle East » Africa
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Impact of Covid-19 and a Looming Global Recession |
Year 2021 in Review and Near Term Outlook |
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2023 |
Impact of COVID-19 on Life Sciences Sector Remains Mixed |
Life Science Tools – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for 33 Players Worldwide in 2022 (E) |
Recent Market Activity |
World Brands |
Life Science Tools: A Prelude |
Market Outlook |
Cell Biology Holds Significant Revenue Stake |
Intertwined Factors with Major Implications for Life Science Domain & Related Tools |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Trends in Life Science Research Sector Support Demand |
3D Cell Culture Transforms Life Sciences Industry |
EXHIBIT: Global 3D Cell Culture Market in US$ Million: 2020 - 2027 |
Increasing Demand for 3D Cell Culture in Drug Discovery |
Use of 3D Cell Culture for Regenerative Medicine |
Proteomics Emerges as an Important Research Tool in Battle against COVID-19 |
Pressing Need for COVID-19 Diagnostics & Therapeutics Accentuates Dynamic Role of Proteomics |
Proteomics Profiling to Expedite Drug Discovery |
Proteomics at the Fore with Latest Advances |
Mass Spectrometry (MS) Expands Application of Proteomics |
AI and Machine Learning Address Shortcomings of Traditional Equipment in Effectively Identifying Protein Patterns |
mRNA Technology Gains Spotlight in Life Sciences |
Innovations in Instrumentation Expand Functionality and Drive Adoption of PCR |
Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years |
EXHIBIT: Global qPCR and dPCR Instrumentation Market in US$ Million: 2020-2025 |
Greater Integration of Genomic Technologies in the Development of Novel Diagnostics Tests |
Next Generation Sequencing Drives the Market Growth |
R&D Activity Remains Vibrant in NGS |
The Need for Large-scale NGS Data Analysis Pushes for Cloud-enabled Bioinformatics Services |
Single-Cell Spatial Biology Technologies Poised to Emerge as an Integral Aspect of Future Labs |
Rising Application of Whole Genome Sequencing Drives Demand for Faster Secondary Analysis Tools |
Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market Prospects |
EXHIBIT: Global BioPharmaceuticals Market in US$ Billion: 2020 and 2026 |
Liquid Chromatography Drives Growth in New Application Markets |
Innovative HPLC Products Inject New Growth |
Digital Transformation of Life Sciences Sector Improves Efficiency and Productivity |
EXHIBIT: Key Initiators of Digital Transformation in Life Sciences |
Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities |
EXHIBIT 15: Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025 |
Technological Developments and Expanding End-Use Applications to Bolster Growth in Mass Spectrometry |
EXHIBIT: Global Chromatography Market (2022): Percentage Share Breakdown of Value Sales by Chromatography Techniques |
Miniature Mass Spectroscopy Instruments Get Popular |
Increase in Healthcare Spending to Propel Demand for Life Science Tools |
EXHIBIT 13: World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023 |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Government & Academics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
JAPAN |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
CHINA |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
EUROPE |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
FRANCE |
France Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
GERMANY |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
SPAIN |
Spain Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Spain Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Spain Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Spain 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
RUSSIA |
Russia Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Russia Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Russia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Russia 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
AUSTRALIA |
Australia Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Australia Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Australia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Australia 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
INDIA |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E) |
India Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
India Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
India Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
India Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
India 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
SOUTH KOREA |
South Korea Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
South Korea Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
South Korea Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
South Korea 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF ASIA-PACIFIC |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Rest of Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Asia-Pacific 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
LATIN AMERICA |
Latin America Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Latin America Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Latin America Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Latin America 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
MIDDLE EAST |
Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E) |
Middle East Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Middle East Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Middle East Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Middle East 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
AFRICA |
Africa Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2012, 2021 & 2027 |
Africa Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Africa Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Africa 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
Total Companies Profiled: 308 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com